
KOSMD Consultitng, Inc.
Your Partner In Wound Healing
We empower the medical provider to improve outcomes through knowledge & application of the latest in cutting edge technologies
We bring our expertise with the goal of helping providers to drive business growth and improved outcomes through implementation of the best in practice & proven cutting edge technologies. We work with provider to establish exceptional wound care services fully covered by Medicare, ensuring that every patient receives top-tier medical attention without financial strain. We help the provider to tailor treatment and integrate of state of the art innovative care to enhance overall health , minimize complications and accelerate recovery.
We provide 24/7 Support
We bring competitive pricing & bulk order discounts
We work closely to ensure a comprehensive understanding of the distinctions between products & how to incorporate
We provide prior authorization at the start and re-run monthly throughout membrane application process
We create a seamless ordering process & provide a HIPPA compliant portal for manage patient orders, track authorizations & shipping, etc.
We partner with leading billing companies to assist in authorizations and provide membrane billing services @ 2.9%
We bring a multifaceted approach to wound care that encompasses improved documentation & optimized healing conditions
We provide Quarterly Up=dates on new and existing membranes • ASP • National Fee Schedule • MUE
Next Day shipping if ordered prior to 3 pm c.s.t.
We Educate
We Coordinate
We Facilitate

Faster Healing • Better Healing • Improved Quality of Life
Faster Healing • Better Healing • Improved Quality of Life

Superior
Wound Healing with
Amniotic Membrane Allografts
The use of amniotic membrane allografts in wound treatment is a not only proven mechanism to accelerate wound healing but also to provide more durable repair. This cutting-edge approach to wound care, capitalizes on the addition of countless healing elements from the donated amniotic membrane. The donor membranes are stripped of their cellular elements that trigger immune response which reduces the inflammation and scarring, while providing elements to provide scaffold for cellular ingrowth and stimulate improve blood supply. Serving as a temporary protective layer, the amniotic allograft accelerates healing and wards off infection.

Proteins • More Collagen • More Fibrin • More Elastin • More Cytokines • More Growth Factors •
Proteins • More Collagen • More Fibrin • More Elastin • More Cytokines • More Growth Factors •

AMNIOTIC MEMBRANES IMPROVE WOUND HEALING BY PROVIDING:
Top Multi-layered Dehydrated Amniotic Membrane Allographs
Protective Covering
Immunogenicity
Angiogenesis
Scaffold
Growth Factors
No statements or implied treatments on this advertisement have been evaluated or approved by the FDA. This advertisement contains no medical advice.
All statements and opinions provided by this advertisement are provided for educational and informational purposes only and is not intended to diagnose nor treat any conditions. SS-009-RevA 10-2021.

Portfolio of Amniotic Membrane Allografts
Portfolio of Amniotic Membrane Allografts
Activate Matrix Q4301
$1934.29 ASP • 480 MUE
Lypholyzed Human Amniotic Membrane (DDHAM)
Allograft Sizes
1×2 cm – ACT-27212
2×2 cm- ACT-27222
2×3 cm – ACT-27223
2×4 cm – ACT-27224
4×4 cm – ACT-27244
4×6 cm – ACT-27246
4×8 cm – ACT-27248
Use of XCell Amnio Matrix:
Diabetic Foot Ulcers (DFUs),
Venous Leg Ulcers (VLUs),
Pressure/Sacral Wounds,
Lacerations
MOHS
Allograft Sizes
7×7 cm – ACT-27277
8x12cm – ACT-27812
9×20 cm – ACT-27920
12×20 cm – ACT-27122
16×20 cm – ACT-27162
20×20 cm – ACT-27202
24×20 cm – ACT-27242
Tissue Harvest Protocol
Donor tissue is obtained through a full-term birth consent program in partnership with FDA regulated and accredited recovery organizations. Maternal screening includes:
Hepatitis B core Anitgen (HBcAg)
Hepatitis C antibodies (HCV Ab)
Human Immunodeficiency Virus
1/O/2 antibodies (HIV-1/O/2 Ab)
Human T-lymphotrophic virus I/II (HTLV-I/II)
Activate™ Placental-Derived Allograft is processed in an ISO Class 5 environment.
3 Layered Amniotic Allograft Amnion • Sponge • Chorion
Gentle, non-oxidative dehydration process.
Minimized protein denaturing
Preserve structural integrity of the extracellular matrix
Terminally Sterilized
5 yr shelf life
Xcell Amnio Matrix. Q4280
$2060.39 ASP • 180 MUE
Lypholyzed Human Amniotic Membrane (DDHAM)
Allograft Sizes
6mm
9mm
12 mm disc
2 ×2 cm
2 x 4 cm
4 x 4 cm
4 x 7 cm
10 x10 cm
10 x 20 cm
Product Code
XAM006
XAM0006
XAM0012
XAM0202
XAM0204
XAM0404
XAM0407
XAM1010
XAM10220
Use of XCell Amnio Matrix:
Diabetic Foot Ulcers (DFUs),
Venous Leg Ulcers (VLUs),
Pressure/Sacral Wounds,
Lacerations
MOHS
Advanced Processing
•DryFlex® Processing
Retains the components found in human amniotic tissue1
Excellent handling and non-side specific application
Molds and conforms upon application
Room temperature storage
5-year shelf life
UPC Code
860011420798
850059651001
850059651018
860011420750
860011420767
860011420774
860011420781
none
none
SimpliMax- Q4341
$3525 National Fee Schedule
Dual-Layer Dehydrated Amniotic Membrane
Dual Layered Membrane
Placental tissue allograft composed of dual layer amnion
Non-side specific orientation for application
Thicker membrane for deep wounds or exposed anatomy that can be easily positioned or repositioned for improved conformity
Enhanced tensile strength, adheres well, and easy to apply
Can be used in a hydrated or dehydrated state
Retains important major structural proteins and ECM biochemicals that are naturally present in placental tissue
UPC
860013115500
860013115524
860013115548
860013115517
860013115531
860013115555
860013115562
Advanced Processing
• Terminally sterilized using gamma irradiation to meet the Sterility Assurance Level of SAL of 1x10-6
• Extensive Donor Screening
• Tissue Processing within 24 hours of acquisition
•
Ease of Use
• EITHER side placed onto wound
• Effective with or without hydration
• DURABILE Enhanced Tensile Strength
• Thickness allows for easy handling & securing
• 5 yr shelf life
Use of SimpliMax:
Diabetic Foot Ulcers (DFUs),
Venous Leg Ulcers (VLUs),
Pressure/Sacral Wounds,
Lacerations
Burn injuries
Reference #
SMAX AA 0202
SMAX AA 0203
SMAX AA 0404
SMAX AA 0406
SMAX AA 0408
SMAX AA 1010
SMAX AA 2024
Sizes
2cmx2cm
2cmx3cm
4cmx4cm
4cmx6cm
4cmx8cm
10cmx10cm
20cm x 24cm
Benefits of SimpliMax
Protective covering & barrier
Scaffold: Extracellular Matrix potentiates the (2) migration and adhesion of resident cells
Enriched with Cytokines & Growth Factors (3)
Anti-inflammatory: L-1ra, IL-4, IL-6, IL-10
Angiogenic: VEGF, TGF-Beta, EGF, PDGF
Cell Proliferation: IGF-1, KGF
Antibacterial: MIP
SimpliMax is packaged as a sterile product in sealed, single-use pouches. SimpliMax is processed in compliance with all current Good Tissue Practices as mandated by the United States Food and Drug Administration and the
American Association of Tissue Banks.
Only tissues from donors meeting the prescribed criteria are processed for manufacturing of SimpliMax
Infectious Disease Screened In Blood Specimens Of Donor
• HTLV I/II, HIV (NAT), HBV (NAT), HCV (NAT), HIV-1/2 antibody, Hepatitis B surface antigen, Hepatitis B core antibody (Total) • Hepatitis C antibody, Malaria, Syphilis, WNV (NAT)
AmnioAmp-MP Q4250
$2850 National Fee Schedule • 24 MUE
Decellularized Dehydrated Human Amniotic Membrane (DDHAM)
Dual Layered Membrane:
Minimally Manipulated
Dehydrated Formulated with patented PūrAMP Process™
retains nutrient growth factors that are essential for signaling
Preservation of the extracellular matrix (ECM), regulatory proteins
Removal of blood contaminants
E-Beam sterilization
1 yer shelf life
Allograft Sizes
2 x 3 cm
2 × 4 c m
2 × 6 cm
Cellular Benefits
Contains cytokines - epidermal, keratinocyte, hepatocyte, and Fibroblast growth factors, fibronectin, laminins, Type 1 & 2 Collagen extracellular matrix
• Non-immunogenic,anti-inflammatory effect and reduces wound desiccation
Product Code
SB1000
SB1001
SB1002
AmnioAMP-MP approved chronic wounds types:
Diabetic Foot Ulcers (DFUs),
Venous Leg Ulcers (VLUs),
Pressure/Sacral Wounds,
Lacerations
Burn injuries
Partial and full-thickness wounds
Acute and chronic wound
Arterial insufficiency wounds,
Wounds with exposed tendon, muscle, and bone.
Advanced Processing
• Terminally sterilized using electron-beam irradiation to meet the Sterility Assurance Level of SAL
• Extensive Donor Screening
• Tissue Processing within 24 hours of acquisition
Allograft Sizes
3×8 cm
4 ×4 cm
2 ×6 cm
16 mm Disk
Product Code
SB1003
SB1004
SB1005
SB1007
Benefits of AmnioAMP-MP
Protective covering & barrier
Immunogenicity: Amniotic is Non-immunologic (1)
Scaffold: Extracellular Matrix potentiates the (2) migration and adhesion of resident cells
Enriched with Cytokines & Growth Factors (3)
ESANO ACA- Q4275
$2652 National Fee Schedule * 480 MUE
Esano ACA is a dehydrated 3-Layer Aniotic Membrane for management of complex wounds.
3 Layered Membrane
• Amnion • Chorion • Amnion
• Enables Omnidirectional/Side Agnostic usage
• Structural Proteins & Extracellular Biochemicals
• All-Natural Cytokines & Growth Factors
Allograft Sizes
2 x 2 cm
2 × 3 c m
2 ×4 cm
Product Code
EsanoACA-0202
EsanoACA-0203
EsanoACA-0204
Esano ACA approved chronic wounds types:
Diabetic Foot Ulcers (DFUs),
Venous Leg Ulcers (VLUs),
Pressure/Sacral Wounds,
Lacerations
Burn injuries
Ease of Use
• EITHER side placed onto wound
• Effective with or without hydration
• DURABILE Enhanced Tensile Strength
• Thickness allows for easy handling & securing
• 5 yr shelf life
Advanced Processing
• Terminally sterilized using electron-beam irradiation to meet the Sterility Assurance Level of SAL
• Extensive Donor Screening
• Tissue Processing within 24 hours of acquisition
• Contains cytokines - epidermal, keratinocyte, hepatocyte, and Fibroblast growth factors
• Non-immunogenic,anti-inflammatory effect and reduces wound desiccation
Allograft Sizes
4 ×4 cm
4 ×6 cm
4 ×8 cm
Product Code
EsanoACA-0404
EsanoACA-0406
EsanoACA-0408
Benefits of Esano ACA
Protective covering & barrier
Immunogenicity: Amniotic is Non-immunologic (1)
Scaffold: Extracellular Matrix potentiates the (2) migration and adhesion of resident cells
Enriched with Cytokines & Growth Factors (3)
[1] Park C, Y, Kohanim S, Zhu L, Gehlbach P, L, Chuck R, S: Immunosuppressive Property of Dried Human Amniotc Membrane. Ophthalmic Res 2009;41:112-113. doi:10.1159/000187629.
[2)Thepresenceofextracellularmatrixw a sconfirmedb yinternalmeasurements of collagen (Sirius Red, Chondrex) a n d Hyaluronic Acid (Hyaluronan Quantkine ELISAKit,R&DSystems).|
[3)Thepresenceofgrowthfactorsconfirmedby3rdpartytestngusing Fluorescent Multplex ELISA (Quantbody® Human Growth Factor Array, Ray BioTech).
(4] Oyen ML, Cook RF, Calvin SE. Mechanical failure of human fetal membrane tissues. J MaterSciMaterMed2004;15:651-658.
[5] Chua WK, Oyen ML. Do w e know the strength of the chorioamnion? Acritical review and analysis. Eur J Obstet Gyn Reprod Biol 2009; 144(Suppl 1): S128-133.
[6Data on File
Esano ACA is manufactured under stringent and high-quality processes in state-of-the-art American Association of Blood Banks (AABB) and American Association of Tissue Banks (AATB) accredited facilities. Evolution Biologic is an FDA-registered biologics company creating human connective tissue matrix technologies. Sourced from C-Section donors from Tissue Banks with Tissue Reference Group (TRG) Certification and in accordance with FDA regulations under 21 CFRPart 1271 ensuring blood testing resulting in clearance of any HIV, HBsAg, HBc Total, HCV, and RPR comorbidities.
Dermabind TL Q 4225
3 Layered Amniotic Membrane: Amnion • Sponge • Chorion
Preserved in dehydrated DermaBind allograft. Including cytokines, collagen matrix, glycoproteins, glycosaminoglycans. The proprietary preservation process of Dermabind is thought to increase the quantity of growth factors in this allograft, boasting the presence of 640 healing elements including: elastin, growth factors, fibrin, collagen & cytokines.
The Sponge layer contains hyaluronic acid;, TGF-B: transforming growth factor; HDF: Hepatocyte derived growth factor; Interleukin -1 antagonists.
FDA 361 DESIGNATED PRODUCT Dermabind TLTM Allograft
By not disrupt the natural state of the placental tissue in our manufacturing process, we deliver an allograft option that is intact from its original state. The DermaBind TL allograft product is the closest to the original state of the biomaterial and the original intent of the 361-product description for minimal manipulation and homologous use. This is also reinforced by our manufacturing process. https://www.fda.gov/media/109176/download
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue Based Products: Minimal Manipulation and Homologous Use
21 CFR Part 1271.10(a):
Image obtained from Frontiers in Bioengineering and Biotechnology
Dermabind: Triple Layer Amniotic Membrane Allograft
Dehydrated, intact placental wound cover.
No separation of the amnion, intermediate and chorion layers
Preserved intermediate layer
Greatest concentration of proteins, cytokines, collagens, and glycoproteins
Dermabind : Natural Biologic Barrier
Terminally Sterilized using Gamma Irradiation
Never Frozen
Completely Free of Preservatives
Non-Immunogenic
Maintains Membrane Shape
Protects Membrane Protein
Enhance Function as Biologic Dressing
Dermabind: Preserved Natural State of the Placenta
Minimally Manipulated
No chemicals during dehydration
No antibiotics during processing
Eliminates risk of antibiotic-resistant bacteria
Eliminates risk of residual irritants
Eliminates risk of chemical denaturation of protein.
Can be applied in layers
Holds sutures well
Easy to handle
Dermabind: Thickest Homologous Allograft
1000 microns/1 mm
1000 microns/1 mm
vs. Single layer is 150 microns thin = 1/6 of a triple layer
vs. Dual Layer is 300-400 microns thin:
A single layer that is folded back onto itself
Amnion and chorion layers.
DermaBind Triple Layer
Goo
Quality Assurance
DermaBind TL is manufactured under cGMP, cGTP, and ISO 13485 requirements and is processed from donors with normal, full-term pregnancies.
Each donor is carefully screened for comprehensive medical and social histories and is tested according to FDA requirements for Relevant Communicable Diseases.
Most placenta donors reside in Salt Lake City with higher statistics of healthier lifestyles and a very
Clean Processing
We don’t use antibiotics or harsh chemicals.
Our aseptic process takes care of this in the cleaning
stage.
No soaps or chemicals used to clean the product,
therefore no need to remove these later.
Drying Process
By using an Evaporative Dryer, we are able to keep the structure of the membrane and provide space.
We fluff up the intermediate layer and dry it so the body can use the scaffolding and space for better use in the patient’s treatment regimen.
Other allografts do not have this space
Radiation Process
The DermaBind radiation process is much less harsh due to our first steps for cleaning.
We use 17.5 kilogray, others can be known to use 25 kilogray.
The protein structure of the biomaterial can be negatively affected due to the use of that much radiation.
“The remarkable advantage I’ve discovered with the DermaBind TL Allograft is the elimination of the need for skin grafts, significantly expediting the healing process by tenfold or more. It’s truly transformative. DermaBind TL is healing even better than the dual layer I have used in the past.
Additional Resources to Improve Diagnosis & Healing
Better Documentation
Portable Easy to use ABI tool
INSTANTANEOUS RESULTS
BILLABLE CODES
Ensure Nutritional Stat
INSTANTANEOUS RESULTS
Subscribe Patient • Prove Results
Register to Order Now
To learn more or to start the process contact us right away.